Screener
Immunome IMNM Business Segments — Net Income Loss
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Immunome’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219425
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 59,331 | 47,562 |
| Loss from operations | (59,331) | (44,636) |
| Interest income | 5,492 | 2,996 |
| Net loss | $(53,839) | $(41,640) |
| Net loss per share, basic and diluted | $(0.48) | $(0.52) |
| Weighted-average shares outstanding, basic and diluted | 113,136,836 | 79,410,354 |
| Comprehensive loss: | ||
| Net loss | $(53,839) | $(41,640) |
Item 1. Financial Statements.
FAQ
- What is Immunome's business segments — net income loss?
- Immunome (IMNM) reported business segments — net income loss of -$53.84M in Q1 2026.
- How has Immunome's business segments — net income loss changed year-over-year?
- Immunome's business segments — net income loss decreased by 29.3% year-over-year, from -$41.64M to -$53.84M.
- What is the long-term trend for Immunome's business segments — net income loss?
- Over 2 years (2023 to 2025), Immunome's business segments — net income loss has grown at a 41.0% compound annual growth rate (CAGR), from -$106.81M to -$212.39M.
- What does business segments — net income loss mean?
- The bottom-line financial result, representing the total profit or loss after all operating expenses, interest, and other non-operating items are accounted for. This is the ultimate measure of the company's financial performance and its ability to generate value for shareholders. It reflects the net impact of all business decisions, including R&D investments and corporate financing activities.
Ask your AI about Immunome's business segments — net income loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude